FDA Inspection 665559 — Amphastar France Pharmaceuticals

Amphastar France Pharmaceuticals — FEI 3003672088

The FDA completed an inspection of Amphastar France Pharmaceuticals on March 23, 2010 in Eragny Sur Epte. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 23, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eragny Sur Epte (France)